Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q1 2020 · 10-Q
Revenue$7.62M$7.62M+1.7% vs Q1 2019 Net Income$686.97K$686.97K+149.0% vs Q1 2019 EPS Diluted$0.08$0.08+166.7% vs Q1 2019 Operating Income$1,249,070+46.3% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Free Cash Flowderived$2,608,602+44.5% Margins · derivedOperating margin16.4%+5.0 pt vs Q1 2019
Net margin9.0%+5.3 pt vs Q1 2019
ended Feb 29, 2020 · filed Apr 14, 2020 · 45 d after period end